ARSL
Basic information
Region (hg38): X:2934045-2968475
Previous symbols: [ "CDPX", "CDPX1", "ARSE" ]
Links
Phenotypes
GenCC
Source:
- X-linked chondrodysplasia punctata 1 (Definitive), mode of inheritance: XLR
- X-linked chondrodysplasia punctata 1 (Supportive), mode of inheritance: XL
- X-linked chondrodysplasia punctata 1 (Definitive), mode of inheritance: XL
- X-linked chondrodysplasia punctata 1 (Strong), mode of inheritance: XL
- X-linked chondrodysplasia punctata 1 (Definitive), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Chondrodysplasia punctata 1, X-linked recessive | XL | Musculoskeletal | Individuals may demonstrate cervical spine stenosis and/or instability, and surveillance may be beneficial to detect and treat (eg, with placement of a cervical collar or spinal fusion) spinal sequelae | Craniofacial; Musculoskeletal; Neurologic | 7720070; 9863597; 12567415; 18348268; 20301713; 20523025; 23462608; 23470839 |
ClinVar
This is a list of variants' phenotypes submitted to
- Chondrodysplasia punctata, brachytelephalangic, autosomal (4 variants)
- not provided (4 variants)
- X-linked chondrodysplasia punctata 1 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARSL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 127 | 11 | 138 | |||
missense | 68 | 17 | 104 | |||
nonsense | 6 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
splice region | 8 | 1 | 9 | |||
non coding | 65 | 51 | 119 | |||
Total | 9 | 18 | 72 | 209 | 70 |
Variants in ARSL
This is a list of pathogenic ClinVar variants found in the ARSL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-2934558-C-G | Benign (Aug 14, 2018) | |||
X-2934561-C-T | Benign (Aug 14, 2018) | |||
X-2934665-A-G | Benign (Jun 26, 2018) | |||
X-2934843-C-T | Chondrodysplasia punctata, brachytelephalangic, autosomal | Uncertain significance (Jul 29, 2023) | ||
X-2934859-C-T | X-linked chondrodysplasia punctata 1 • See cases • Inborn genetic diseases • Chondrodysplasia punctata, brachytelephalangic, autosomal | Pathogenic/Likely pathogenic (Dec 19, 2024) | ||
X-2934860-C-T | Pathogenic (May 30, 2024) | |||
X-2934870-G-A | X-linked chondrodysplasia punctata 1 | Pathogenic (Mar 01, 2003) | ||
X-2934874-C-T | not specified • Chondrodysplasia punctata, brachytelephalangic, autosomal | Benign (Feb 01, 2024) | ||
X-2934891-G-A | Pathogenic (Oct 24, 2016) | |||
X-2934898-C-T | Chondrodysplasia punctata, brachytelephalangic, autosomal | Benign (Dec 21, 2023) | ||
X-2934908-A-C | X-linked chondrodysplasia punctata 1 • Chondrodysplasia punctata, brachytelephalangic, autosomal | Conflicting classifications of pathogenicity (Jan 31, 2024) | ||
X-2934910-G-A | not specified • X-linked chondrodysplasia punctata 1 • Chondrodysplasia punctata, brachytelephalangic, autosomal | Benign (Feb 01, 2024) | ||
X-2934916-C-G | not specified • Chondrodysplasia punctata, brachytelephalangic, autosomal | Likely benign (Mar 14, 2023) | ||
X-2934930-G-T | Chondrodysplasia punctata, brachytelephalangic, autosomal • not specified | Uncertain significance (Aug 12, 2022) | ||
X-2934937-A-G | Chondrodysplasia punctata, brachytelephalangic, autosomal | Likely benign (Sep 21, 2023) | ||
X-2934943-G-A | Chondrodysplasia punctata, brachytelephalangic, autosomal | Likely benign (May 20, 2023) | ||
X-2934949-T-A | Chondrodysplasia punctata, brachytelephalangic, autosomal | Likely benign (Dec 10, 2022) | ||
X-2934959-T-A | Chondrodysplasia punctata, brachytelephalangic, autosomal | Uncertain significance (Sep 19, 2022) | ||
X-2934967-C-T | Chondrodysplasia punctata, brachytelephalangic, autosomal | Likely benign (May 12, 2023) | ||
X-2934969-C-T | Chondrodysplasia punctata, brachytelephalangic, autosomal | Uncertain significance (Oct 05, 2022) | ||
X-2934970-C-T | Chondrodysplasia punctata, brachytelephalangic, autosomal | Likely benign (Nov 17, 2023) | ||
X-2934973-C-T | Connective tissue disorder • Chondrodysplasia punctata, brachytelephalangic, autosomal | Conflicting classifications of pathogenicity (Sep 20, 2023) | ||
X-2934976-C-T | Chondrodysplasia punctata, brachytelephalangic, autosomal | Likely benign (Oct 06, 2023) | ||
X-2934982-T-C | Chondrodysplasia punctata, brachytelephalangic, autosomal | Likely benign (Jul 25, 2023) | ||
X-2934983-C-T | Chondrodysplasia punctata, brachytelephalangic, autosomal | Likely benign (Jan 29, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ARSL | protein_coding | protein_coding | ENST00000381134 | 10 | 33588 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.590 | 0.410 | 125742 | 1 | 4 | 125747 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.95 | 173 | 262 | 0.660 | 0.0000223 | 3844 |
Missense in Polyphen | 55 | 117 | 0.47008 | 1690 | ||
Synonymous | 0.612 | 110 | 118 | 0.929 | 0.0000117 | 1191 |
Loss of Function | 2.98 | 3 | 15.8 | 0.190 | 0.00000122 | 234 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000761 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000722 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000368 | 0.0000264 |
Middle Eastern | 0.0000722 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May be essential for the correct composition of cartilage and bone matrix during development. Has no activity toward steroid sulfates.;
- Disease
- DISEASE: Chondrodysplasia punctata 1, X-linked recessive (CDPX1) [MIM:302950]: A clinically and genetically heterogeneous disorder characterized by punctiform calcification of the bones. CDPX1 is a congenital defect of bone and cartilage development characterized by aberrant bone mineralization, severe underdevelopment of nasal cartilage, and distal phalangeal hypoplasia. This disease can also be induced by inhibition with the drug warfarin. {ECO:0000269|PubMed:12567415, ECO:0000269|PubMed:7720070, ECO:0000269|PubMed:9409863}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Estrogen metabolism;Metabolism of lipids;Post-translational protein modification;Metabolism of proteins;The activation of arylsulfatases;Gamma carboxylation, hypusine formation and arylsulfatase activation;Androgen and estrogen biosynthesis and metabolism;Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.0978
Intolerance Scores
- loftool
- 0.124
- rvis_EVS
- 0.29
- rvis_percentile_EVS
- 71.51
Haploinsufficiency Scores
- pHI
- 0.167
- hipred
- N
- hipred_score
- 0.403
- ghis
- 0.385
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.974
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- skeletal system development
- Cellular component
- endoplasmic reticulum lumen;Golgi apparatus;Golgi stack;extracellular exosome
- Molecular function
- arylsulfatase activity;metal ion binding